Most searched LCDs
Monthly US Google searches for the policy number (Google Ads, October 2026). Glucose monitors, oxygen, power mobility and the molecular diagnostics policies lead because their edits deny high-volume claims.
| LCD | Title | Contractor | Revised | Covered codes | Searches / month |
|---|---|---|---|---|---|
| L33822 | Glucose Monitors | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-10-01 | 461 | 110 |
| L35041 | Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds | Novitas Solutions, Inc. | 2019-09-26 | 1 | 110 |
| L33394 | Drugs and Biologicals, Coverage of, for Label and Off-Label Uses | Wellpoint Federal | 2026-07-13 | 2,953 | 70 |
| L33627 | Non-Invasive Vascular Studies | Wellpoint Federal | 2026-04-01 | 2,110 | 70 |
| L33789 | Power Mobility Devices | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2025-10-01 | — | 70 |
| L33318 | Knee Orthoses | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-01-25 | 4,806 | 50 |
| L33686 | Ankle-Foot/Knee-Ankle-Foot Orthosis | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-04-01 | 12 | 50 |
| L33718 | Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-01-01 | 1 | 50 |
| L33792 | Wheelchair Options/Accessories | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2025-10-01 | — | 50 |
| L33797 | Oxygen and Oxygen Equipment | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2023-04-01 | — | 50 |
| L33831 | Surgical Dressings | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-01-01 | — | 50 |
| L35936 | Facet Joint Interventions for Pain Management | Wellpoint Federal | 2026-04-09 | 24 | 50 |
| L38814 | MolDX: Minimal Residual Disease Testing for Cancer | Noridian Healthcare Solutions, LLC | 2026-02-05 | 1,194 | 50 |
| L33794 | External Infusion Pumps | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-07-01 | 460 | 40 |
| L34892 | Facet Joint Interventions for Pain Management | Novitas Solutions, Inc. | 2024-08-11 | 20 | 40 |
Titles published by several contractors
Each comparison page lists every version with its states, revision date and covered-code count. The full topic list follows the contractor table.
By contractor
Most recently revised
A revision that added or removed diagnosis codes explains most sudden changes in denial volume; check the date of service against the revision date.
| LCD | Title | Contractor | Revised | Covered codes |
|---|---|---|---|---|
| L40265 | Peripheral Nerve Injections and Procedures for Chronic Pain | Noridian Healthcare Solutions, LLC | 2026-11-01 | 43 |
| L33622 | Pain Management - Injection of tendon sheaths, ligaments, bursa, and ganglion cysts | Wellpoint Federal | 2026-10-25 | 232 |
| L40261 | Peripheral Nerve Injections and Procedures for Chronic Pain | CGS Administrators, LLC | 2026-10-25 | 43 |
| L40263 | Peripheral Nerve Injections and Procedures for Chronic Pain | Palmetto GBA | 2026-10-25 | 43 |
| L40267 | Peripheral Nerve Injections and Procedures for Chronic Pain | Wellpoint Federal | 2026-10-25 | 43 |
| L40300 | Peripheral Nerve Injections and Procedures for Chronic Pain | Wisconsin Physicians Service Insurance Corporation | 2026-10-25 | 43 |
| L40210 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | Palmetto GBA | 2026-10-12 | 680 |
| L40222 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | Noridian Healthcare Solutions, LLC | 2026-10-12 | 680 |
| L40226 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | CGS Administrators, LLC | 2026-10-12 | 680 |
| L40238 | MolDX: Genetic Testing for Hereditary Thrombophilia | Palmetto GBA | 2026-10-12 | 1,171 |
| L40242 | MolDX: Genetic Testing for Hereditary Thrombophilia | Noridian Healthcare Solutions, LLC | 2026-10-12 | 1,171 |
| L40259 | MolDX: Genetic Testing for Hereditary Thrombophilia | CGS Administrators, LLC | 2026-10-12 | 1,171 |
| L40274 | MolDX: Genetic Testing for Hereditary Thrombophilia | Wisconsin Physicians Service Insurance Corporation | 2026-10-12 | 1,171 |
| L40278 | MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer | Wisconsin Physicians Service Insurance Corporation | 2026-10-12 | 680 |
| L34356 | Erythropoiesis Stimulating Agents (ESA) | CGS Administrators, LLC | 2026-10-04 | 1,253 |
All multi-contractor topics (169)
- 4Kscore Test Algorithm (2)
- Allergen Immunotherapy (2)
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) (5)
- Allergy Diagnostic Testing (5)
- Allergy Testing (4)
- Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin (4)
- Ambulatory Electrocardiograph (AECG) Monitoring (2)
- Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (7)
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) (5)
- Autonomic Function Testing (2)
- Autonomic Function Tests (2)
- B-type Natriuretic Peptide (BNP) Testing (5)
- BDX-XL2 (3)
- BRCA1 and BRCA2 Genetic Testing (2)
- Blepharoplasty, Eyelid Surgery, and Brow Lift (2)
- Blepharoplasty, Blepharoptosis Repair and Surgical Procedures of the Brow (2)
- Bone Mass Measurement (2)
- Botulinum Toxin Injections (6)
- Botulinum Toxins (2)
- Cardiac Catheterization and Coronary Angiography (2)
- Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA) (2)
- Cardiology Non-emergent Outpatient Stress Testing (2)
- Cardiovascular Nuclear Medicine (2)
- Cataract Extraction (4)
- Cataract Surgery (2)
- Cervical Fusion (7)
- Chiropractic Services (2)
- Colon Capsule Endoscopy (CCE) (7)
- Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy (2)
- Computed Tomography Cerebral Perfusion Analysis (CTP) (4)
- Controlled Substance Monitoring and Drugs of Abuse Testing (2)
- Corneal Hysteresis (3)
- Corneal Pachymetry (3)
- Cosmetic and Reconstructive Surgery (5)
- Cystatin C Measurement (2)
- Debridement Services (2)
- Diagnostic Colonoscopy (2)
- Electroretinography (ERG) (3)
- Endovenous Stenting (2)
- Epidural Steroid Injections for Pain Management (7)
- Erythropoiesis Stimulating Agents (4)
- Facet Joint Interventions for Pain Management (7)
- Frequency of Hemodialysis (7)
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs) (2)
- Genetic Testing for Cardiovascular Disease (2)
- Genetic Testing in Oncology: Specific Tests (2)
- GlycoMark® Testing for Glycemic Control (3)
- Hospice - Determining Terminal Status (2)
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (6)
- Immune Globulin (2)
- Implantable Continuous Glucose Monitors (I-CGM) (7)
- In Vitro Chemosensitivity & Chemoresistance Assays (2)
- Intervertebral Disc Repair (3)
- Intraoperative Neurophysiological Testing (2)
- Intravenous Immune Globulin (2)
- Lab: Bladder/Urothelial Tumor Markers (2)
- Lab: Coenzyme Q10 (CoQ10) (2)
- Lab: Cystatin C Measurement (2)
- Lab: Flow Cytometry (2)
- Lab: Special Histochemical Stains and Immunohistochemical Stains (4)
- MDS FISH (4)
- Magnetic Resonance Angiography (MRA) (4)
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor (3)
- Micro-Invasive Glaucoma Surgery (MIGS) (7)
- Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (3)
- Mohs Micrographic Surgery (MMS) (6)
- MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (4)
- MolDX: Biomarkers in Cardiovascular Risk Assessment (4)
- MolDX: Blood Product Molecular Antigen Typing (4)
- MolDX: Breast Cancer Assay: Prosigna® (4)
- MolDX: Breast Cancer Index® (BCI) Gene Expression Test (4)
- MolDX: DecisionDx-UM (Uveal Melanoma) (3)
- MolDX: EndoPredict Breast Cancer Gene Expression Test (4)
- MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test (4)
- MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (4)
- MolDX: Genetic Testing for Hereditary Thrombophilia (4)
- MolDX: Genetic Testing for Heritable Thoracic Aortic Disease (4)
- MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (4)
- MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (3)
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer (4)
- MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (4)
- MolDX: MGMT Promoter Methylation Analysis (4)
- MolDX: Melanoma Risk Stratification Molecular Testing (4)
- MolDX: Minimal Residual Disease Testing for Cancer (4)
- MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (4)
- MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (4)
- MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (4)
- MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (4)
- MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (4)
- MolDX: Molecular Diagnostic Tests (MDT) (4)
- MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (4)
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (4)
- MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (4)
- MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (4)
- MolDX: Molecular Testing for Solid Organ Allograft Rejection (5)
- MolDX: NRAS Genetic Testing (4)
- MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (4)
- MolDX: Next-Generation Sequencing for Solid Tumors (4)
- MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer (4)
- MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (4)
- MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) (4)
- MolDX: Pharmacogenomics Testing (4)
- MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (3)
- MolDX: Pigmented Lesion Assay (4)
- MolDX: Plasma-Based Genomic Profiling in Solid Tumors (4)
- MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (4)
- MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (4)
- MolDX: Prometheus® IBD sgi Diagnostic® Policy (4)
- MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (4)
- MolDX: Repeat Germline Testing (4)
- Molecular Pathology Procedures (2)
- Nerve Blocks for Peripheral Neuropathy (2)
- Nerve Conduction Studies and Electromyography (7)
- Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (5)
- Non-Invasive Vascular Studies (2)
- Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities (2)
- Off-label Use of Rituximab and Rituximab Biosimilars (2)
- Ophthalmic Angiography (Fluorescein and Indocyanine Green) (2)
- Ophthalmic Biometry for Intraocular Lens Power Calculation (2)
- Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography) (2)
- Outpatient Physical and Occupational Therapy Services (2)
- Panretinal (Scatter) Laser Photocoagulation (2)
- Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (2)
- Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) (5)
- Peripheral Nerve Blocks (2)
- Peripheral Nerve Injections and Procedures for Chronic Pain (5)
- Peripheral Venous Ultrasound (2)
- Pharmacogenomics Testing (2)
- Platelet Rich Plasma (4)
- Platelet Rich Plasma Injections for Non-Wound Injections (2)
- Polysomnography and Other Sleep Studies (3)
- ProMark® Risk Score (4)
- Proton Beam Therapy (2)
- Psychiatric Inpatient Hospitalization (4)
- Psychiatric Partial Hospitalization Programs (2)
- Psychiatry and Psychology Services (2)
- RAST Type Tests (2)
- Removal of Benign Skin Lesions (3)
- Respiratory Pathogen Panel Testing (3)
- Routine Foot Care (3)
- Routine Foot Care and Debridement of Nails (2)
- Sacroiliac Joint Injections and Procedures (5)
- Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) (6)
- Somatosensory Testing (4)
- Speech-Language Pathology (3)
- Spinal Cord Stimulators for Chronic Pain (2)
- Stretta Procedure (2)
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) (5)
- Surgical Treatment of Nails (3)
- Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices (3)
- Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain (2)
- Total Joint Arthroplasty (4)
- Transcranial Magnetic Stimulation (TMS) (6)
- Transesophageal Echocardiography (TEE) (3)
- Transthoracic Echocardiography (TTE) (2)
- Transurethral Waterjet Ablation of the Prostate (5)
- Treatment of Chronic Venous Insufficiency of the Lower Extremities (2)
- Treatment of Males with Low Testosterone (2)
- Treatment of Varicose Veins of the Lower Extremities (3)
- Trigger Point Injections (TPI) (7)
- Upper Gastrointestinal Endoscopy and Visualization (2)
- Urine Drug Testing (5)
- Urodynamics (2)
- Varicose Veins of the Lower Extremity, Treatment of (2)
- Visual Electrophysiology Testing (2)
- Visual Fields Testing (2)
- Vitamin D Assay Testing (5)
- Wireless Capsule Endoscopy (3)
- Wound Care (3)
All active LCDs (862)
- L33252 Psychiatric Diagnostic Evaluation and Psychotherapy Services
- L33261 Allergy Testing
- L33267 B-Type Natriuretic Peptide (BNP)
- L33274 Botulinum Toxins
- L33312 Wheelchair Seating
- L33317 External Breast Prostheses
- L33318 Knee Orthoses
- L33369 Therapeutic Shoes for Persons with Diabetes
- L33370 Nebulizers
- L33393 Hospice - Determining Terminal Status
- L33394 Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
- L33396 Posterior Tibial Nerve Stimulation for Voiding Dysfunction
- L33398 Transcranial Magnetic Stimulation
- L33399 EEG – Ambulatory Monitoring
- L33405 Polysomnography and Sleep Testing
- L33411 Surgical Management of Morbid Obesity
- L33417 Allergy Skin Testing
- L33420 Lab: Bladder/Urothelial Tumor Markers
- L33423 Cardiac Computed Tomography & Angiography (CCTA)
- L33428 Cosmetic and Reconstructive Surgery
- L33431 HbA1c
- L33436 Mohs Micrographic Surgery (MMS)
- L33438 Octreotide Acetate for Injectable Suspension (Sandostatin® LAR Depot)
- L33444 Pulmonary Stress Testing
- L33445 Removal of Benign and Malignant Skin Lesions
- L33446 Respiratory Therapy and Oximetry Services
- L33447 Special Electroencephalography
- L33449 Swallowing Studies for Dysphagia
- L33455 Wireless Gastrointestinal Motility Monitoring Systems
- L33456 Total Joint Arthroplasty
- L33457 Cardiac Radionuclide Imaging
- L33459 Computerized Axial Tomography (CT), Thorax
- L33461 Implantable Infusion Pump
- L33467 Ophthalmology: Extended Ophthalmoscopy and Fundus Photography
- L33557 Cardiac Catheterization and Coronary Angiography
- L33558 Cataract Extraction
- L33559 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33560 Cardiovascular Nuclear Medicine
- L33563 Incision and Drainage (I & D) of Abscess of Skin, Subcutaneous and Accessory Structures
- L33567 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L33569 Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
- L33573 B-type Natriuretic Peptide (BNP) Testing
- L33574 Visual Fields Testing
- L33575 Varicose Veins of the Lower Extremity, Treatment of
- L33576 Urodynamics
- L33577 Transthoracic Echocardiography (TTE)
- L33578 Transrectal Ultrasound
- L33579 Transesophageal Echocardiography (TEE)
- L33580 Speech-Language Pathology
- L33583 Diagnostic and Therapeutic Esophagogastroduodenoscopy
- L33585 Breast Imaging: Breast Echography (Sonography)/Breast MRI/Ductography
- L33591 RAST Type Tests
- L33609 Autonomic Function Tests
- L33610 Intravenous Immune Globulin
- L33611 Oral Appliances for Obstructive Sleep Apnea
- L33612 Suction Pumps
- L33614 Debridement Services
- L33616 Osteopathic Manipulative Treatment
- L33618 Major Joint Replacement (Hip and Knee)
- L33619 Nonvascular Extremity Ultrasound
- L33621 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L33622 Pain Management - Injection of tendon sheaths, ligaments, bursa, and ganglion cysts
- L33623 Percutaneous Coronary Intervention
- L33624 Psychiatric Inpatient Hospitalization
- L33626 Psychiatric Partial Hospitalization Programs
- L33627 Non-Invasive Vascular Studies
- L33628 Panretinal (Scatter) Laser Photocoagulation
- L33630 Corneal Pachymetry
- L33631 Outpatient Physical and Occupational Therapy Services
- L33632 Psychiatry and Psychology Services
- L33633 Magnetic Resonance Angiography (MRA)
- L33636 Routine Foot Care and Debridement of Nails
- L33641 Orthopedic Footwear
- L33642 Pressure Reducing Support Surfaces - Group 2
- L33671 Diagnostic Colonoscopy
- L33674 Duplex Scanning
- L33686 Ankle-Foot/Knee-Ankle-Foot Orthosis
- L33689 Mohs Micrographic Surgery (MMS)
- L33690 Automatic External Defibrillators
- L33692 Pressure Reducing Support Surfaces - Group 3
- L33693 Peripheral Venous Ultrasound
- L33695 Non-invasive Extracranial Arterial Studies
- L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea
- L33733 Canes and Crutches
- L33735 Cold Therapy
- L33736 Commodes
- L33737 Eye Prostheses
- L33738 Facial Prostheses
- L33739 Speech Generating Devices (SGD)
- L33751 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L33756 Transesophageal Echocardiogram
- L33766 Visual Field Examination
- L33771 Vitamin D; 25 hydroxy, includes fraction(s), if performed
- L33774 Wireless Capsule Endoscopy
- L33784 Heating Pads and Heat Lamps
- L33785 High Frequency Chest Wall Oscillation Devices
- L33786 Intrapulmonary Percussive Ventilation System
- L33787 Lower Limb Prostheses
- L33788 Manual Wheelchair Bases
- L33789 Power Mobility Devices
- L33790 Spinal Orthoses: TLSO and LSO
- L33791 Walkers
- L33792 Wheelchair Options/Accessories
- L33793 Refractive Lenses
- L33794 External Infusion Pumps
- L33795 Mechanical In-exsufflation Devices
- L33796 Osteogenesis Stimulators
- L33797 Oxygen and Oxygen Equipment
- L33799 Patient Lifts
- L33800 Respiratory Assist Devices
- L33801 Seat Lift Mechanisms
- L33802 Transcutaneous Electrical Nerve Stimulators (TENS)
- L33803 Urological Supplies
- L33813 Destruction of Malignant Skin Lesions
- L33818 Excision of Malignant Skin Lesions
- L33820 Hospital Beds And Accessories
- L33821 Negative Pressure Wound Therapy Pumps
- L33822 Glucose Monitors
- L33823 Cervical Traction Devices
- L33824 Immunosuppressive Drugs
- L33825 Infrared Heating Pad Systems
- L33826 Oral Anticancer Drugs
- L33827 Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
- L33828 Ostomy Supplies
- L33830 Pressure Reducing Support Surfaces - Group 1
- L33831 Surgical Dressings
- L33832 Tracheostomy Care Supplies
- L33833 Surgical Treatment of Nails
- L33906 Epidural Steroid Injections for Pain Management
- L33912 Trigger Point Injections
- L33922 Nail Debridement
- L33923 Noninvasive Ear or Pulse Oximetry For Oxygen Saturation
- L33930 Facet Joint Interventions for Pain Management
- L33933 Peripheral Nerve Blocks
- L33937 Proton Beam Radiotherapy
- L33941 Routine Foot Care
- L33942 Physical Therapy - Home Health
- L33943 B-type Natriuretic Peptide (BNP) Testing
- L33944 Blepharoplasty
- L33945 Cerumen (Earwax) Removal
- L33946 Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
- L33947 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33950 Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
- L33954 Cataract Extraction
- L33958 Somatosensory Testing
- L33959 Cardiac Catheterization and Coronary Angiography
- L33960 Cardiovascular Nuclear Medicine
- L33966 Vestibular Function Tests
- L33967 Vitamin B<sub>12</sub> Injections
- L33975 Psychiatric Inpatient Hospitalization
- L33977 Transcranial Doppler Studies
- L33996 Vitamin D Assay Testing
- L33999 Corneal Pachymetry
- L34005 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L34007 Immune Globulin
- L34008 Computerized Corneal Topography
- L34018 Parathormone (Parathyroid Hormone)
- L34021 Sedimentation Rate, Erythrocyte
- L34027 Ultrasound, Soft Tissues of Head and Neck
- L34028 Blepharoplasty, Blepharoptosis Repair and Surgical Procedures of the Brow
- L34032 Debridement Services
- L34037 Flow Cytometry
- L34045 Non-Invasive Vascular Studies
- L34046 Speech-Language Pathology
- L34049 Outpatient Physical and Occupational Therapy Services
- L34056 Urodynamics
- L34061 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34062 Dialysis Access Maintenance
- L34063 RAST Type Tests
- L34064 Panretinal (Scatter) Laser Photocoagulation
- L34081 Endoscopy by Capsule
- L34082 Varicose Veins of the Lower Extremity, Treatment of
- L34084 Transcatheter Infusion Therapy
- L34085 Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
- L34087 Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
- L34090 Laser Ablation of the Prostate
- L34149 Respiratory Care
- L34163 Total Hip Arthroplasty
- L34171 Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
- L34175 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L34181 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L34183 Psychiatric Inpatient Hospitalization
- L34194 Blepharoplasty, Eyelid Surgery, and Brow Lift
- L34195 Mohs Micrographic Surgery
- L34196 Psychiatric Partial Hospitalization Programs
- L34200 Removal of Benign Skin Lesions
- L34203 Cataract Surgery in Adults
- L34209 Treatment of Varicose Veins of the Lower Extremities
- L34211 Trigger Point Injections (TPI)
- L34213 Diagnostic and Therapeutic Colonoscopy
- L34215 Lab: Flow Cytometry
- L34218 Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
- L34220 Lumbar MRI
- L34228 Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
- L34233 Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
- L34246 Routine Foot Care and Debridement of Nails
- L34313 Allergy Testing
- L34314 Immune Globulin Intravenous (IVIg)
- L34315 Electrocardiograms
- L34324 Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
- L34328 Peripheral Nerve Stimulation
- L34337 Transesophageal Echocardiography (TEE)
- L34338 Transthoracic Echocardiography (TTE)
- L34353 Outpatient Psychiatry and Psychology Services
- L34356 Erythropoiesis Stimulating Agents (ESA)
- L34372 Magnetic Resonance Angiography (MRA)
- L34380 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34393 Ocular Photography - External
- L34394 Visual Fields Testing
- L34399 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L34410 B-type Natriuretic Peptide (BNP) Testing
- L34411 Blepharoplasty, Eyelid Surgery, and Brow Lift
- L34413 Cataract Surgery
- L34415 CT of the Abdomen and Pelvis
- L34417 CT of the Head
- L34419 Homocysteine Level, Serum
- L34424 Magnetic Resonance Angiography
- L34425 Magnetic Resonance Imaging of the Head and Neck
- L34426 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L34427 Outpatient Occupational Therapy
- L34428 Outpatient Physical Therapy
- L34429 Outpatient Speech Language Pathology
- L34430 Respiratory Therapy (Respiratory Care)
- L34431 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34433 Somatosensory Testing
- L34434 Upper Gastrointestinal Endoscopy and Visualization
- L34454 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L34512 Corneal Pachymetry
- L34513 Lab: Flow Cytometry
- L34519 Molecular Pathology Procedures
- L34520 Psychological and Neuropsychological Tests
- L34521 Special EEG Tests
- L34522 Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder
- L34526 Surgical Treatment of Obstructive Sleep Apnea (OSA)
- L34528 Blepharoplasty, Blepharoptosis and Brow Lift
- L34536 Treatment of Varicose Veins of the Lower Extremities
- L34537 Vestibular Function Testing
- L34538 Hospice Determining Terminal Status
- L34539 Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
- L34540 Stretta Procedure
- L34541 Transtelephonic Spirometry
- L34544 Hospice - Liver Disease
- L34547 Hospice - Neurological Conditions
- L34548 Hospice Cardiopulmonary Conditions
- L34551 One Day Stays for Chest Pain
- L34552 Outpatient Observation Bed/Room Services
- L34553 Stretta Procedure
- L34554 In Vitro Chemosensitivity & Chemoresistance Assays
- L34558 Hospice The Adult Failure To Thrive Syndrome
- L34559 Hospice - Renal Care
- L34560 Home Health Occupational Therapy
- L34561 Home Health - Psychiatric Care
- L34562 Home Health Skilled Nursing Care-Teaching and Training: Alzheimer's Disease and Behavioral Disturbances
- L34563 Home Health Speech-Language Pathology
- L34564 Home Health Physical Therapy
- L34565 Home Health-Surface Electrical Stimulation in the Treatment of Dysphagia
- L34567 Hospice Alzheimer's Disease & Related Disorders
- L34570 Psychiatric Inpatient Hospitalization
- L34575 Frequency of Hemodialysis
- L34576 Laparoscopic Sleeve Gastrectomy for Severe Obesity
- L34577 Retroperitoneal Ultrasound
- L34578 Surface Electrical Stimulation in the Treatment of Dysphagia
- L34580 Intravenous Immunoglobulin (IVIG)
- L34594 Nerve Conduction Studies and Electromyography
- L34596 Immunizations
- L34614 Colonoscopy and Sigmoidoscopy-Diagnostic
- L34615 Visual Fields
- L34616 Psychiatry and Psychology Services
- L34623 Intraoperative Neurophysiological Testing
- L34624 Somatosensory Testing
- L34633 Erythropoiesis Stimulating Agents (ESAs)
- L34636 Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring)
- L34641 Transcranial Magnetic Stimulation (TMS)
- L34645 Urine Drug Testing
- L34646 Psychological and Neuropsychological Testing
- L34648 Bisphosphonate Drug Therapy
- L34658 Vitamin D Assay Testing
- L34659 Endoscopic Treatment of GERD
- L34760 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34761 Percutaneous Coronary Interventions
- L34771 Immune Globulins
- L34821 Transcutaneous Electrical Joint Stimulation Devices (TEJSD)
- L34823 Tumor Treatment Field Therapy (TTFT)
- L34824 Vacuum Erection Devices (VED)
- L34833 Cardiac Rhythm Device Evaluation
- L34859 Nerve Conduction Studies and Electromyography
- L34865 Magnetic Resonance Angiography (MRA)
- L34869 Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults
- L34887 Surgical Treatment of Nails
- L34892 Facet Joint Interventions for Pain Management
- L34912 Genetic Testing for Lynch Syndrome
- L34914 Assays for Vitamins and Metabolic Function
- L34924 Treatment of Chronic Venous Insufficiency of the Lower Extremities
- L34938 Removal of Benign Skin Lesions
- L34961 Mohs Micrographic Surgery (MMS)
- L34975 Neurophysiology Evoked Potentials (NEPs)
- L34976 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L34998 Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder
- L35000 Molecular Pathology Procedures
- L35001 Reduction Mammaplasty
- L35003 Intraoperative Neurophysiological Testing
- L35004 Blepharoplasty, Blepharoptosis Repair and Surgical Procedures of the Brow
- L35006 Controlled Substance Monitoring and Drugs of Abuse Testing
- L35007 Vestibular and Audiologic Function Studies
- L35010 Trigger Point Injections
- L35013 Debridement of Mycotic Nails
- L35014 Frequency of Hemodialysis
- L35016 Transesophageal Echocardiography (TEE)
- L35022 Bariatric Surgical Management of Morbid Obesity
- L35025 MolDX: Molecular Diagnostic Tests (MDT)
- L35026 Rituximab
- L35028 Venous Angioplasty with or without Stent Placement for the Treatment of Chronic Cerebrospinal Venous Insufficiency
- L35035 Thoracic Aortography and Carotid, Vertebral, and Subclavian Angiography
- L35038 Scanning Computerized Ophthalmic Diagnostic Imaging
- L35041 Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds
- L35048 Nerve Conduction Studies and Electromyography
- L35049 Monitored Anesthesia Care
- L35050 Outpatient Sleep Studies
- L35062 Biomarkers Overview
- L35070 Speech - Language Pathology (SLP) Services: Communication Disorders
- L35073 MolDX: NRAS Genetic Testing
- L35074 Heavy Metal Testing
- L35075 Proton Beam Therapy
- L35076 Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
- L35080 Select Minimally Invasive GERD Procedures
- L35081 Nerve Conduction Studies and Electromyography
- L35083 Cardiology Non-emergent Outpatient Stress Testing
- L35089 Wireless Capsule Endoscopy
- L35090 Cosmetic and Reconstructive Surgery
- L35091 Cataract Extraction (including Complex Cataract Surgery)
- L35092 Diagnostic Abdominal Aortography and Renal Angiography
- L35093 Immune Globulin
- L35098 Nerve Conduction Studies and Electromyography
- L35099 Frequency of Laboratory Tests
- L35101 Psychiatric Codes
- L35121 Coronary Computed Tomography Angiography (CCTA)
- L35124 Autonomic Function Testing
- L35125 Wound Care
- L35130 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L35132 Home Health Plans of Care: Monitoring Glucose Control in the Medicare Home Health Population with Type II Diabetes Mellitus
- L35136 Spinal Cord Stimulators for Chronic Pain
- L35138 Routine Foot Care
- L35160 MolDX: Molecular Diagnostic Tests (MDT)
- L35163 Plastic Surgery
- L35170 Botulinum Toxin Injections
- L35172 Botulinum Toxin Injections
- L35222 Nerve Blocks for Peripheral Neuropathy
- L35249 Nerve Blocks for Peripheral Neuropathy
- L35350 Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)
- L35391 Multiple Imaging in Oncology
- L35395 Autonomic Function Tests
- L35396 Biomarkers for Oncology
- L35397 Non-Invasive Cerebrovascular Arterial Studies
- L35434 Oximetry Services
- L35442 MolDX: NRAS Genetic Testing
- L35451 Peripheral Venous Ultrasound
- L35456 Nerve Blockade for Treatment of Chronic Pain and Neuropathy
- L35486 Pelvic Floor Dysfunction: Anorectal Manometry and EMG
- L35490 Category III Codes
- L35494 Mohs Micrographic Surgery
- L35498 Removal of Benign Skin Lesions
- L35526 B-type Natriuretic Peptide (BNP) Testing
- L35677 Infliximab
- L35702 Mohs Micrographic Surgery
- L35724 Urine Drug Testing
- L35751 Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
- L35753 Non-Invasive Cerebrovascular Studies
- L35755 Non-Invasive Abdominal / Visceral Vascular Studies
- L35761 Non-Invasive Peripheral Arterial Vascular Studies
- L35891 Intravenous Immune Globulin
- L35897 Nerve Conduction Studies and Electromyography
- L35906 Somatosensory Testing
- L35922 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L35936 Facet Joint Interventions for Pain Management
- L35974 MolDX: MGMT Promoter Methylation Analysis
- L35984 MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L35986 Special Histochemical Stains and Immunohistochemical Stains
- L35998 Non-Coronary Vascular Stents
- L36000 Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain
- L36007 Lower Extremity Major Joint Replacement (Hip and Knee)
- L36021 MolDX: Molecular Diagnostic Tests (MDT)
- L36029 Urine Drug Testing
- L36039 Total Joint Arthroplasty
- L36089 MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L36113 MolDX: MGMT Promoter Methylation Analysis
- L36125 MolDX: Breast Cancer Assay: Prosigna®
- L36129 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36139 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36155 MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L36188 MolDX: MGMT Promoter Methylation Analysis
- L36236 Autonomic Function Testing
- L36240 Allergen Immunotherapy
- L36241 Allergy Testing
- L36267 Bowel Management Devices
- L36335 MolDX: NRAS Genetic Testing
- L36351 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L36353 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L36358 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36377 Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities
- L36380 MolDX: Breast Cancer Assay: Prosigna®
- L36393 Controlled Substance Monitoring and Drugs of Abuse Testing
- L36400 MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
- L36402 Allergy Testing
- L36406 Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint
- L36408 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L36425 MolDX: Breast Cancer Assay: Prosigna®
- L36427 Wireless Capsule Endoscopy
- L36460 Bone Mass Measurement
- L36464 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L36469 Transcranial Magnetic Stimulation (TMS)
- L36485 <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b>
- L36499 BRCA1 and BRCA2 Genetic Testing
- L36523 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36524 Nerve Conduction Studies and Electromyography
- L36538 Treatment of Males with Low Testosterone
- L36551 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L36575 Total Knee Arthroplasty
- L36593 Polysomnography
- L36658 Proton Beam Therapy
- L36665 ProMark® Risk Score
- L36668 Urine Drug Testing
- L36675 ProMark® Risk Score
- L36678 Lab: Bladder/Urothelial Tumor Markers
- L36690 Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
- L36692 Vitamin D Assay Testing
- L36702 Serum Magnesium
- L36704 ProMark® Risk Score
- L36715 BRCA1 and BRCA2 Genetic Testing
- L36761 GlycoMark® Testing for Glycemic Control
- L36767 Aortography and peripheral angiography
- L36797 MolDX: NRAS Genetic Testing
- L36805 Lab: Special Histochemical Stains and Immunohistochemical Stains
- L36807 MolDX: Molecular Diagnostic Tests (MDT)
- L36811 MolDX: Breast Cancer Assay: Prosigna®
- L36831 Visual Electrophysiology Testing
- L36839 Polysomnography and Other Sleep Studies
- L36846 Measurement of Salivary Hormones
- L36850 Peripheral Nerve Blocks
- L36861 Polysomnography and Other Sleep Studies
- L36864 GlycoMark® Testing for Glycemic Control
- L36902 Polysomnography and Other Sleep Studies
- L36906 GlycoMark® Testing for Glycemic Control
- L36912 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L36920 Epidural Steroid Injections for Pain Management
- L36941 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L36951 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L36975 Bladder/Urothelial Tumor Markers
- L37001 MolDX: MGMT Promoter Methylation Analysis
- L37003 MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
- L37011 ProMark® Risk Score
- L37015 Visual Electrophysiology Testing
- L37022 Lab: Coenzyme Q10 (CoQ10)
- L37031 BDX-XL2
- L37033 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37054 BDX-XL2
- L37066 Lab: Coenzyme Q10 (CoQ10)
- L37070 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37086 Transcranial Magnetic Stimulation (TMS)
- L37126 Coenzyme Q10 (CoQ10)
- L37130 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37166 Wound Care
- L37176 White Cell Colony Stimulating Factors
- L37199 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L37205 Chemotherapy Drugs and their Adjuncts
- L37210 MolDX: Decision Dx-UM (Uveal Melanoma)
- L37216 BDX-XL2
- L37228 Wound Care
- L37244 Micro-Invasive Glaucoma Surgery (MIGS)
- L37254 Chiropractic Services
- L37260 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L37264 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37295 MolDX: EndoPredict® Breast Cancer Gene Expression Test
- L37299 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L37352 MolDX: Prometheus IBD sgi Diagnostic® Policy
- L37356 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37371 Electroretinography (ERG)
- L37373 MRI and CT Scans of the Head and Neck
- L37379 Echocardiography
- L37387 Chiropractic Services
- L37398 Electroretinography (ERG)
- L37475 Frequency of Hemodialysis
- L37502 Frequency of Hemodialysis
- L37531 Micro-Invasive Glaucoma Surgery (MIGS)
- L37535 Vitamin D Assay Testing
- L37537 Frequency of Hemodialysis
- L37539 MolDX: Prometheus® IBD sgi Diagnostic® Policy
- L37547 Chest X-Ray Policy
- L37561 Cystatin C Measurement
- L37564 Frequency of Hemodialysis
- L37575 Frequency of Hemodialysis
- L37578 Micro-Invasive Glaucoma Surgery (MIGS)
- L37581 Lab: Cystatin C Measurement
- L37598 Cystatin C Measurement
- L37602 MDS FISH
- L37606 Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases
- L37608 MDS FISH
- L37616 Lab: Cystatin C Measurement
- L37620 MDS FISH
- L37628 In Vitro Chemosensitivity & Chemoresistance Assays
- L37632 Spinal Cord Stimulators for Chronic Pain
- L37633 Partial Hospitalization Programs
- L37638 Health and Behavior Assessment/Intervention
- L37641 Continuous Peripheral Nerve Blocks (CPNB)
- L37642 Nerve Blocks and Electrostimulation for Peripheral Neuropathy
- L37643 Routine Foot Care
- L37644 YAG Capsulotomy
- L37663 MolDX: EndoPredict® Breast Cancer Gene Expression Test
- L37725 MolDX: Melanoma Risk Stratification Molecular Testing
- L37729 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
- L37750 MolDX: Melanoma Risk Stratification Molecular Testing
- L37772 MDS FISH
- L37774 Supervised Exercise Therapy for the Treatment of Peripheral Arterial Disease with Symptomatic Lower Extremity Intermittent Claudication
- L37779 Intraoperative Radiation Therapy
- L37792 4Kscore Test Algorithm
- L37794 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37798 4Kscore Test Algorithm
- L37800 Allergen Immunotherapy
- L37810 Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
- L37822 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37826 Lumbar Artificial Disc Replacement
- L37832 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37848 Lumbar Spinal Fusion
- L37857 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L37863 Voretigene Neparvovec-rzyl (Luxturna®)
- L37870 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L37873 Topical Oxygen Therapy
- L37887 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L37893 Endovenous Stenting
- L37897 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L37903 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L37905 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L37913 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37919 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L37921 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L38014 Corneal Hysteresis
- L38016 MolDX: Melanoma Risk Stratification Molecular Testing
- L38018 MolDX: Melanoma Risk Stratification Molecular Testing
- L38026 Corneal Hysteresis
- L38033 Cervical Disc Replacement
- L38043 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38045 MolDX: Next-Generation Sequencing for Solid Tumors
- L38047 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38051 MolDX: Pigmented Lesion Assay
- L38065 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38067 MolDX: Next-Generation Sequencing for Solid Tumors
- L38070 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38111 MolDX: Pigmented Lesion Assay
- L38119 MolDX: Next-Generation Sequencing for Solid Tumors
- L38123 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38151 MolDX: Pigmented Lesion Assay
- L38158 MolDX: Next-Generation Sequencing for Solid Tumors
- L38168 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38176 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38178 MolDX: Pigmented Lesion Assay
- L38201 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L38211 Corneal Hysteresis
- L38213 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L38223 Micro-Invasive Glaucoma Surgery (MIGS)
- L38227 Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
- L38229 Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
- L38231 Endovenous Stenting
- L38233 Micro-Invasive Glaucoma Surgery (MIGS)
- L38238 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38240 MolDX: Blood Product Molecular Antigen Typing
- L38249 MolDX: Blood Product Molecular Antigen Typing
- L38268 Immune Thrombocytopenia (ITP) Therapy
- L38274 MolDX: Repeat Germline Testing
- L38276 Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
- L38278 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L38284 MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
- L38288 MolDX: Repeat Germline Testing
- L38292 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38294 MolDX: Pharmacogenomics Testing
- L38299 Micro-Invasive Glaucoma Surgery (MIGS)
- L38303 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38307 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38310 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38327 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38331 MolDX: Blood Product Molecular Antigen Typing
- L38335 MolDX: Pharmacogenomics Testing
- L38339 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38351 MolDX: Repeat Germline Testing
- L38367 Fluid Jet System Treatment for LUTS/BPH
- L38371 Multimarker Serum Tests Related to Ovarian Cancer Testing
- L38378 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- L38385 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38387 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38394 MolDX: Pharmacogenomics Testing
- L38396 Cardiology Non-emergent Outpatient Stress Testing
- L38398 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38429 MolDX: Repeat Germline Testing
- L38433 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38435 MolDX: Pharmacogenomics Testing
- L38441 MolDX: Blood Product Molecular Antigen Typing
- L38443 MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
- L38495 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
- L38506 Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
- L38528 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38549 Transurethral Waterjet Ablation of the Prostate
- L38551 Transanal Endoscopic Surgery (TES)
- L38566 MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells
- L38571 Colon Capsule Endoscopy (CCE)
- L38576 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38584 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38586 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38613 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L38617 Implantable Continuous Glucose Monitors (I-CGM)
- L38623 Implantable Continuous Glucose Monitors (I-CGM)
- L38643 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38647 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38657 Implantable Continuous Glucose Monitors (I-CGM)
- L38662 Implantable Continuous Glucose Monitors (I-CGM)
- L38664 Implantable Continuous Glucose Monitors (I-CGM)
- L38667 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38678 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38682 Transurethral Waterjet Ablation of the Prostate
- L38684 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38686 Implantable Continuous Glucose Monitors (I-CGM)
- L38694 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38705 Transurethral Waterjet Ablation of the Prostate
- L38709 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38712 Transurethral Waterjet Ablation of the Prostate
- L38720 Treatment of Chronic Venous Insufficiency of the Lower Extremities
- L38726 Transurethral Waterjet Ablation of the Prostate
- L38737 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L38743 Implantable Continuous Glucose Monitors (I-CGM)
- L38745 Platelet Rich Plasma
- L38747 Peroral Endoscopic Myotomy (POEM)
- L38755 Colon Capsule Endoscopy (CCE)
- L38765 Facet Joint Interventions for Pain Management
- L38769 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38771 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L38773 Facet Joint Interventions for Pain Management
- L38775 Extracorporeal Shock Wave Therapy (ESWT)
- L38777 Colon Capsule Endoscopy (CCE)
- L38779 MolDX: Minimal Residual Disease Testing for Cancer
- L38786 Echocardiography for Myocardial Perfusion
- L38792 Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®)
- L38801 Facet Joint Interventions for Pain Management
- L38805 Colon Capsule Endoscopy (CCE)
- L38807 Colon Capsule Endoscopy (CCE)
- L38809 Botulinum Toxins
- L38812 Diagnostic Colonoscopy
- L38814 MolDX: Minimal Residual Disease Testing for Cancer
- L38822 MolDX: Minimal Residual Disease Testing for Cancer
- L38824 Colon Capsule Endoscopy (CCE)
- L38835 MolDX: Minimal Residual Disease Testing for Cancer
- L38837 Colon Capsule Endoscopy (CCE)
- L38839 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L38841 Facet Joint Interventions for Pain Management
- L38902 Wound and Ulcer Care
- L38914 Cosmetic and Reconstructive Surgery
- L38916 Respiratory Pathogen Panel Testing
- L38918 Respiratory Pathogen Panel Testing
- L38920 Off-label Use of Rituximab and Rituximab Biosimilars
- L38926 Cataract Extraction (including Complex Cataract Surgery)
- L38937 Platelet Rich Plasma
- L38953 Parenteral Nutrition
- L38955 Enteral Nutrition
- L38966 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L38968 Thyroid Nodule Molecular Testing
- L38970 Advance Care Planning
- L38972 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L38985 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L38988 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L38992 Electroretinography (ERG)
- L38994 Epidural Steroid Injections for Pain Management
- L38997 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L39001 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39005 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L39015 Epidural Steroid Injections for Pain Management
- L39017 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L39023 Platelet Rich Plasma Injections for Non-Wound Injections
- L39027 Respiratory Pathogen Panel Testing
- L39036 Epidural Steroid Injections for Pain Management
- L39038 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39040 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L39042 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L39044 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39051 Cosmetic and Reconstructive Surgery
- L39054 Epidural Steroid Injections for Pain Management
- L39058 Platelet Rich Plasma Injections for Non-Wound Injections
- L39063 Pharmacogenomics Testing
- L39068 Platelet Rich Plasma
- L39071 Platelet Rich Plasma
- L39073 Pharmacogenomics Testing
- L39075 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L39080 Cardiac Resynchronization Therapy (CRT)
- L39082 Genetic Testing for Cardiovascular Disease
- L39084 Genetic Testing for Cardiovascular Disease
- L39086 Treatment of Males with Low Testosterone
- L39116 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39121 Treatment of Varicose Veins of the Lower Extremities
- L39128 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39139 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39189 Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG)
- L39226 Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)
- L39230 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L39237 Erythropoiesis Stimulating Agents
- L39240 Epidural Steroid Injections for Pain Management
- L39256 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39258 Surgical Treatment of Nails
- L39260 Hyaluronic Acid Injections for Knee Osteoarthritis
- L39262 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39266 Cognitive Assessment and Care Plan Service
- L39268 Bone Mass Measurement
- L39270 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39276 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39284 Prostate Cancer Detection with IsoPSA®
- L39297 Off-label Use of Rituximab and Rituximab Biosimilars
- L39314 Off-Label Use of Intravenous Immune Globulin (IVIG)
- L39345 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39356 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39365 Genetic Testing in Oncology: Specific Tests
- L39367 Genetic Testing in Oncology: Specific Tests
- L39373 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39383 Sacroiliac Joint Injections and Procedures
- L39385 Near-Infrared Spectroscopy in Wound and Flap Management
- L39387 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
- L39389 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39391 Vitamin D Assay Testing
- L39396 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39400 Magnesium
- L39402 Sacroiliac Joint Injections and Procedures
- L39420 Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
- L39424 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39427 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39434 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39455 Sacroiliac Joint Injections and Procedures
- L39462 Sacroiliac Joint Injections and Procedures
- L39467 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39475 Sacroiliac Joint Injections and Procedures
- L39477 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39479 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39481 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39490 Ambulatory Electrocardiograph (AECG) Monitoring
- L39492 Ambulatory Electrocardiograph (AECG) Monitoring
- L39506 Cosmetic and Reconstructive Surgery
- L39513 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin
- L39521 Positron Emission Tomography (PET) Scan for Inflammation and Infection
- L39529 Intraarticular Knee Injections of Hyaluronan
- L39543 Sacral Nerve Stimulation for the Treatment of Urinary and Fecal Incontinence
- L39553 Radiation Therapies
- L39573 Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia
- L39575 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39583 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39585 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39589 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39591 External Upper Limb Tremor Stimulator Therapy
- L39611 Urine Drug Testing
- L39614 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39616 Urinary Biomarkers for Chronic Pain Management
- L39624 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39636 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39642 Intraosseous Basivertebral Nerve Ablation
- L39646 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L39648 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39650 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L39654 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39656 Trigger Point Injections (TPI)
- L39658 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39662 Trigger Point Injections (TPI)
- L39671 Trigger Point Injections (TPI)
- L39678 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39682 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L39686 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39709 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39711 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39713 Trigger Point Injections
- L39720 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L39726 KidneyIntelX and KidneyIntelX.dkd Testing
- L39741 Cervical Fusion
- L39758 Cervical Fusion
- L39770 Cervical Fusion
- L39773 Cervical Fusion
- L39780 Lower Esophageal Magnetic Sphincter Augmentation
- L39788 Cervical Fusion
- L39793 Cervical Fusion
- L39797 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L39799 Cervical Fusion
- L39802 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L39810 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L39832 Botulinum Toxin Injections
- L39836 Botulinum Toxin Injections
- L39840 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L39849 Opioid Treatment Programs
- L39851 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L39853 Outpatient Psychotherapy
- L39857 Botulinum Toxin Injections
- L39863 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L39877 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39879 Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39881 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA)
- L39905 Cataract Surgery
- L39907 Micro-Invasive Glaucoma Surgery (MIGS)
- L39909 Botulinum Toxin Injections
- L39911 Total Joint Arthroplasty
- L39913 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L39919 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L39923 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L39933 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L39935 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39938 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L39940 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39942 Intervertebral Disc Repair
- L39944 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L39948 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39956 Total Shoulder Arthroplasty
- L39958 Intervertebral Disc Repair
- L39960 Intervertebral Disc Repair
- L39987 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39989 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L39995 Pharmacogenomic Testing
- L40000 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L40022 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L40046 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40048 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40050 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40056 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40058 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40060 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40062 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40140 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40168 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40176 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40179 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40187 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40189 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40193 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40197 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40199 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40205 Irreversible Electroporation for Cancer
- L40210 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40222 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40224 Automated Detection and Quantification of Brain MRIs
- L40226 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40228 Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities
- L40232 Total Joint Arthroplasty
- L40238 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40242 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40244 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40249 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40255 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40257 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40259 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40261 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40263 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40265 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40267 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40272 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40274 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40276 Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities
- L40278 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40289 Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities
- L40300 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40302 Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
- L40324 Allergy Diagnostic Testing
- L40326 Allergy Diagnostic Testing
- L40328 Allergy Diagnostic Testing
- L40330 Allergy Diagnostic Testing
- L40334 Erythropoiesis Stimulating Agents
- L40341 Allergy Diagnostic Testing
How to use this list
A Local Coverage Determination applies only inside the jurisdiction of the contractor that wrote it, so the first filter is geography and the second is the date of service. Open the policy for the contractor that processes the claim, read its covered indications and limitations, and then open the billing and coding article for the diagnosis and procedure codes the claims system tests; the LCD pages here show the article's covered-code count with a sample and link to the full list on cms.gov. Where a title appears at several contractors, the comparison page shows how far the versions have drifted, which matters for groups that bill across state lines. The LCD lookup guide covers jurisdiction assignment and the appeal path, the NCD guide explains when a national policy overrides a local one, and the HCPCS drug code pages list the articles that mention each code.
Frequently asked questions
How many Medicare LCDs are there?
The Medicare Coverage Database export of September 24, 2026 carries 862 active Local Coverage Determinations across the A/B, DME and home health contractors, plus proposed policies not yet in force. Many are the same title written by several contractors, which is why this hub groups them into topics.
What is the difference between an LCD and its article?
The LCD states the clinical indications, limitations and documentation requirements. Since January 2019 the ICD-10-CM, CPT and HCPCS codes live in a companion Billing and Coding Article, which is what contractors load as the claims edit. Each LCD page here shows both.
Why do two LCDs with the same title have different codes?
Each contractor maintains its own policy for its jurisdiction. Policies are often copied from one contractor to another and then revised separately, so the covered diagnosis lists drift. The topic comparison pages line the versions up by state, revision date and list size.
Which LCD applies to my state?
The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished for professional and institutional claims, or the DME MAC region for equipment. The contractor hubs list every active policy per jurisdiction.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file lcd.csvSHA-256 2fcc4251b6ddd1eb…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-09-24 · effective 2026-09-20 · file article.csvSHA-256 f31932f1df3b4035…
Disclaimer
Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.